Home/Filings/4/0001276840-26-000006
4//SEC Filing

MULROY DENNIS 4

Accession 0001276840-26-000006

CIK 0001370053other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 7:14 PM ET

Size

9.2 KB

Accession

0001276840-26-000006

Insider Transaction Report

Form 4
Period: 2026-01-07
MULROY DENNIS
CHIEF FINANCIAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-07+6,70024,367 total
  • Sale

    Common Stock

    2026-01-08$44.71/sh2,515$112,44621,852 total
  • Exercise/Conversion

    Restricted Stock Unit

    2026-01-076,70020,100 total
    Common Stock (6,700 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
  • [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
  • [F3]The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

ANAPTYSBIO, INC

CIK 0001370053

Entity typeother

Related Parties

1
  • filerCIK 0001276840

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 7:14 PM ET
Size
9.2 KB